Semirapid Detection of Piperacillin/Tazobactam Resistance and Extended-Spectrum Resistance to β-Lactams/β-Lactamase Inhibitors in Clinical Isolates of Escherichia coli
Sulbactam
Tazobactam
Piperacillin/tazobactam
Amp resistance
DOI:
10.1128/spectrum.00801-21
Publication Date:
2021-10-25T16:21:39Z
AUTHORS (6)
ABSTRACT
Piperacillin/tazobactam (TZP) is a β-lactam/β-lactamase inhibitor (BL/BLI) recommended for the empirical treatment of severe infections. The excessive and indiscriminate use TZP has promoted emergence TZP-resistant Escherichia coli isolates. Recently, we demonstrated that may contribute to development
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (27)
CITATIONS (10)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....